Mostafa M. Elgebaly

681 total citations
15 papers, 586 citations indexed

About

Mostafa M. Elgebaly is a scholar working on Physiology, Neurology and Epidemiology. According to data from OpenAlex, Mostafa M. Elgebaly has authored 15 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Mostafa M. Elgebaly's work include Nitric Oxide and Endothelin Effects (6 papers), Acute Ischemic Stroke Management (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Mostafa M. Elgebaly is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Acute Ischemic Stroke Management (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Mostafa M. Elgebaly collaborates with scholars based in United States and Czechia. Mostafa M. Elgebaly's co-authors include Adviye Ergul, Weiguo Li, Susan C. Fagan, Adviye Ergul, Kamakshi Sachidanandam, Askiel Bruno, Maribeth H. Johnson, Alex K. Harris, Safia Ogbi and Roshini Prakash and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Mostafa M. Elgebaly

15 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mostafa M. Elgebaly United States	13	234	209	158	110	108	15	586
Aisha I. Kelly-Cobbs United States	9	246 1.1×	169 0.8×	124 0.8×	66 0.6×	77 0.7×	9	507
Safia Ogbi United States	16	197 0.8×	216 1.0×	148 0.9×	109 1.0×	130 1.2×	29	877
Maha Coucha United States	17	246 1.1×	190 0.9×	131 0.8×	85 0.8×	62 0.6×	33	719
Jing-Cheng Li China	16	96 0.4×	155 0.7×	86 0.5×	49 0.4×	89 0.8×	27	634
Jiro Kitayama Japan	10	89 0.4×	141 0.7×	92 0.6×	42 0.4×	92 0.9×	21	411
Mallikarjuna R. Pabbidi United States	15	135 0.6×	53 0.3×	157 1.0×	90 0.8×	161 1.5×	24	729
Zsolt Springó United States	7	143 0.6×	66 0.3×	130 0.8×	51 0.5×	77 0.7×	12	504
Francesco Iemolo Italy	15	168 0.7×	128 0.6×	254 1.6×	16 0.1×	106 1.0×	25	598
Wenli Sheng China	13	69 0.3×	63 0.3×	151 1.0×	80 0.7×	77 0.7×	39	641
Guangkuo Dong United States	11	242 1.0×	84 0.4×	58 0.4×	28 0.3×	40 0.4×	19	579

Countries citing papers authored by Mostafa M. Elgebaly

Since Specialization

Citations

This map shows the geographic impact of Mostafa M. Elgebaly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa M. Elgebaly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa M. Elgebaly more than expected).

Fields of papers citing papers by Mostafa M. Elgebaly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa M. Elgebaly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa M. Elgebaly. The network helps show where Mostafa M. Elgebaly may publish in the future.

Co-authorship network of co-authors of Mostafa M. Elgebaly

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa M. Elgebaly. A scholar is included among the top collaborators of Mostafa M. Elgebaly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa M. Elgebaly. Mostafa M. Elgebaly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Elgebaly, Mostafa M.. (2020). Ephrin–Eph Signaling as a Novel Neuroprotection Path in Ischemic Stroke. Journal of Molecular Neuroscience. 70(12). 2001–2006. 7 indexed citations

Coucha, Maha, et al.. (2019). Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats. PLoS ONE. 14(1). e0210523–e0210523. 24 indexed citations

Elgebaly, Mostafa M., et al.. (2019). Targets, Treatments, and Outcomes Updates in Diabetic Stroke. Journal of Stroke and Cerebrovascular Diseases. 28(6). 1413–1420. 5 indexed citations

Elgebaly, Mostafa M., Safia Ogbi, Weiguo Li, et al.. (2011). Neurovascular Injury in Acute Hyperglycemia and Diabetes: a Comparative Analysis in Experimental Stroke. Translational Stroke Research. 2(3). 391–398. 50 indexed citations

Kelly-Cobbs, Aisha I., et al.. (2010). Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control. Acta Physiologica. 203(1). 245–251. 33 indexed citations

Kelly-Cobbs, Aisha I., Alex K. Harris, Mostafa M. Elgebaly, et al.. (2010). Endothelial Endothelin B Receptor-Mediated Prevention of Cerebrovascular Remodeling Is Attenuated in Diabetes Because of Up-Regulation of Smooth Muscle Endothelin Receptors. Journal of Pharmacology and Experimental Therapeutics. 337(1). 9–15. 30 indexed citations

Elgebaly, Mostafa M., Roshini Prakash, Weiguo Li, et al.. (2010). Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling. Journal of Cerebral Blood Flow & Metabolism. 30(12). 1928–1938. 73 indexed citations

Ergul, Adviye, Weiguo Li, Mostafa M. Elgebaly, Askiel Bruno, & Susan C. Fagan. (2009). Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature. Vascular Pharmacology. 51(1). 44–49. 91 indexed citations

Sachidanandam, Kamakshi, Jim Hutchinson, Mostafa M. Elgebaly, et al.. (2009). Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 296(4). R952–R959. 43 indexed citations

10.

Sachidanandam, Kamakshi, et al.. (2008). Differential Effects of Diet-Induced Dyslipidemia and Hyperglycemia on Mesenteric Resistance Artery Structure and Function in Type 2 Diabetes. Journal of Pharmacology and Experimental Therapeutics. 328(1). 123–130. 23 indexed citations

11.

Sachidanandam, Kamakshi, Mostafa M. Elgebaly, Alex K. Harris, et al.. (2008). Effect of chronic and selective endothelin receptor antagonism on microvascular function in Type 2 diabetes. American Journal of Physiology-Heart and Circulatory Physiology. 294(6). H2743–H2749. 23 indexed citations

12.

Elgebaly, Mostafa M., Alex K. Harris, Hazem Elewa, et al.. (2008). Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1This article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin.. Canadian Journal of Physiology and Pharmacology. 86(6). 358–364. 21 indexed citations

13.

Harris, Alex K., Mostafa M. Elgebaly, Weiguo Li, Kamakshi Sachidanandam, & Adviye Ergul. (2008). Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 294(4). R1213–R1219. 43 indexed citations

14.

Elgebaly, Mostafa M., Vera Portik‐Dobos, Kamakshi Sachidanandam, et al.. (2007). Differential effects of ETA and ETB receptor antagonism on oxidative stress in type 2 diabetes. Vascular Pharmacology. 47(2-3). 125–130. 24 indexed citations

15.

Ergul, Adviye, Mostafa M. Elgebaly, Weiguo Li, et al.. (2007). Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurology. 7(1). 33–33. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact